Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor

Journal of Physiology and Pharmacology

Volumn 55, Issue 4, 2004, Pages 773-790

  Brzozowska, I ^a   Targosz, A ^a   Sliwowski, Z ^a   Kwiecien, S ^a   Drozdowicz, D ^a   Pajdo, R ^a   Konturek, P C ^b   Brzozowski, Tomasz ^a   Pawlik, M ^a   Konturek, S J ^a   Pawlik, W W ^a   Hahn, E G ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aspirin; Diabetes mellitus; Interleukin 1beta; Nitric oxide; Rofecoxib; Tumor necrosis factor alpha; Ulcer healing

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; ROFECOXIB; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; MALE; MICROCIRCULATION; NONHUMAN; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN DETERMINATION; RAT; STOMACH BLOOD FLOW; STOMACH MUCOSA; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING;

ANIMALS; ASPIRIN; CHRONIC DISEASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; MALE; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; STOMACH ULCER;

EID: 19944425992     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Goldin E, Ardite E, Elizalde JI, et al. Gastric mucosal damage in experimental diabetes in rats: role of endogenous gluthatione. Gastroenterology 1997; 112: 855-863.
2. Korolkiewicz R, Tashima K, Kubomi M, Kalo S, Takeuchi K. Increased susceptibility of diabetic rat gastric mucosa to food deprivation during cold stress. Digestion 1999; 60: 528-537.
3. Tashima K, Fujita A, Takeuchi K. Aggravation of ischemia/reperfusion- induced gastric lesions in streptozotocin-diabetic rats. Life Sci 2000; 67: 1707-1718.
4. Tashima K, Fujita A, Umeda M, Takeuchi K. Lack of gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in the stomach of diabetic rats. Life Sci. 2000; 67: 1639-1652.
5. Takehara K, Tashima K, Takeuchi K. Alterations in duodenal bicarbonate secretion and mucosal susceptibility to acid in diabetic rats. Gastroenterology 1997; 112: 418-428.
6. Takeuchi K, Takehara K, Tajima K, Kato S, Hirata T. Impaired healing of gastric lesions in streptozotocin-induced diabetic rats: effect of basic fibroblast growth factor. J Pharm Exp Ther 1997; 281: 200-207.
7. Tashima K, Korolkiewicz R, Kubomi M, Takeuchi K. Increased susceptibility of gastric mucosa to ulcerogenic stimulation in diabetic rats-role of capsaicin-sensitive sensory neurons. Br J Pharmacol 1998; 124: 1359-1402.
8. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002; 97: 604-611.
9. O'Reilly D, Long RG. Diabetes and the gastro-intestinal tract. Digest Dis 1987; 5: 57-64.
10. Masuda H, Inoue S, Arakawa H, Koizumi K, Kubo N. Peptic ulcer in diabetes mellitus. Gastroenterol Jap 1977; 11: 1-4.
11. Pietzsch M, Theuer S, Haase G, Plath F, Keyser M, Riethling AK. Results of systematic screening for serious gastrointestinal bleeding associated with NSAIDs in Rostock hospitals. Int J Clin Pharmacol Ther 2002; 40: 111-115.
12. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001; 32: 215-217.
13. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibupro-fen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984; 13: 19-24.
14. Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336: 840-843.
15. Konturek PK, Brzozowski T, Konturek SJ, Dembinski A. Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesion. Gastroenterology 1990; 99: 1607-1615.
16. Wang JY, Yamasaki S, Takeuchi K, Okabe S. Delayed healing of acetic acid-induced gastric ulcer in rats indomethacin. Gastroenterology 1989; 96: 393-402.
17. Wallace JL, Reuter B, Cicala C, McKnight W, Grishman M, Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 1994; 257: 249-255.
18. Elliott SN, McKnight W, Cirino G, Wallace JL. A nitric oxide-releasing non steroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 109: 524-530.
19. Wallace JL, Mc Knigth W, Del Soldato P, Bavdoun AR, Cirino G. Anti-thrombotic effects of a nitric oxide-releasing, gastric sparing aspirin derivative. J Clin Invest 1995; 96: 2711-2718.
20. Wallace JL, Cirino G, McKnight G, Elliott SN. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybuthlester. Eur J Pharmacol 1995; 280: 63-68.
21. Davies NM, Rosenth AG, Appleyard CB, et al. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther 1997; 11: 69-79.
22. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
23. Vane JR, Bolting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995; 44: 1-10.
24. Fiorucci S, Santucci C, Gresele P, del Soldato P, Morelli A. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers; a proof of concept endoscopic study. Gastroenterology 2003; 124: 600-607.
25. Brzozowski T, Konturek PC, Konturek SJ, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 2001; 53: 343-353.
26. Okabe S, Roth JL, Pfeiffer CJ. A method for experimental, penetrating gastric and duodenal ulcers in rats. Am J Dig Dis 1971; 16: 277-284.
27. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993; 239: 215-217.
28. Konturek, PC, Brzozowski T, Konturek SJ, Drozdowicz D, Pajdo R, Hahn EG. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Scand J Gastroenterol 1997; 32: 6-15.
29. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-611.
30. Brzozowski T, Drozdowicz D, Szlachcic A, Pytko-Polonczyk J, Majka J, Konturek SJ. Role of nitric oxide and prostaglandins in gastroprotection induced by capsaicin and papaverine. Digestion 1993; 54: 24-31.
31. Brzozowski T, Konturek PC, Konturek SJ, et al. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur J Pharmacol 1999; 385: 47-61.
32. Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses. J Physiol Pharmacol 1998; 49: 501-513.
33. Takeuchi K, Yasuhiro T, Asada Y, Sugawa Y. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats. Digestion 1998; 59: 298-307.
34. Davies NM, Sharkey KA, Asfaha S, McNaughton WK, Wallace JL. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997; 11: 1101-1108.
35. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol 1997; 273: 1246-1251.
36. Harsch IA, Brzozowski T, Bazela K, et al. Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines. Eur J Pharmacol 2003; 481: 249-260.
37. Abdel-Salam OM, Czimmer J, Debreceni A, Szolcsanyi J, Mozsik G. Gastric mucosal integrity: gastric mucosal blood flow and microcirculation. An overview. J Physiol Paris 2001; 95: 105-127.
38. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 2002; 51: 603-10.
39. De La Cruz JP, Guerrero A, Paniego MJ, et al. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 96-101.
40. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-62.
41. Kwiecien S, Brzozowski T, Konturek PC, Konturek SJ. The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions. J Physiol Pharmacol 2002; 53: 761-774.
42. 2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. J Physiol Pharmacol 2001; 52: 107-26.
43. Schmassmann A, Peskar BM, Stettler C, et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1997; 123: 795-804.
44. Lesch CA, Gilbertsen RB, Song Y, et al. Effect of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats. J Pharm Exp Ther 1998; 287: 301-306.
45. Kwiecien S, Brzozowski T, Konturek SJ. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol 2002; 53: 39-50.
46. Kwiecien S, Brzozowski T, Konturek PC, et al. The role of reactive oxygen species and capsaicin-sensitive sensory nerves in the pathomechanism of gastric ulcers induced by stress. J Physiol Pharmacol 2003; 54: 423-37.
47. Suzuki H, Shimosegawa T, Satoh A, et al. Gastric mucosal blood flow response to stress in streptozotocin diabetic rats: regulatory role of nitric oxide. J Gastroenterol 1997; 32: 726-33.
48. Sharifi AM, Mousavi SH, Larijani B. Study of interaction between nitric oxide and ACE activity in STZ-induced diabetic rats: role of insulin. Pharmacol Res 2004; 50: 261-6.
49. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106: 373-384.
50. Le J, Vilcek J. Tumor necrosis factor and interleukin 1. Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 324-248.
51. Diamond JR, Pesek I. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. Lab Invest 1991; 64: 21-28.
52. Troost E, Hold GL, Smith MG, et al. The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can J Gastroenterol 2003; 17 (Suppl B): 8B-12B.
53. Brzozowski T, Konturek PC, Konturek SJ, et al. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers. Eur J Pharmacol 2000; 398: 147-158.
54. Brzozowski T, Konturek PC, Konturek SJ, et al. Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin. Inter J Colorectal Dis 2003; 18: 320-29.
55. Brzozowski T, Konturek PC, Konturek SJ, et al. Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: Role of cytokines and gastrin-somatostatin link. Digestion 1999; 60: 22-33.
56. Takahashi S, Shigeta J, Inoue H, et al. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am J Physiol 1998; 275: G1137-G1145.
57. Shigeta J, Takahashi S, Okabe S. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 1998; 286: 1383-1390.
58. Nakamura E, Takahashi S, Matsui, et al. Interleukin-1β inhibits growth factor-stimulated restoration of wounded rat gastric epithelial cell monolayers. Dig Dis Sci 1998; 43: 476-84.
59. Warzecha Z, Dembinski A, Ceranowicz P, et al. IGF-1 stimulates production of interleukin-10 and inhibits development of cerulein-induced pancreatitis. J Physiol Pharmacol 2003; 54: 561-73.
60. Kwiecien S, Brzozowski T, Konturek PC, et al. Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinfiammatory cytokines. J Physiol Pharmacol 2004; 55: 337-55.
61. Fiorucci S, Santucci L, Cirino G, et al. IL-1β converting enzyme is a target for nitric oxide-releasing aspirin: new insight in the antiinflammatory mechanism of nitric oxide-relapsing nonsteroidal anti-inflammatory drugs. J Immune 2000; 65: 5245-5254.